C-Peptide Decline in Type 1 Diabetes Has Two Phases: An Initial Exponential Fall and a Subsequent Stable Phase
Author(s) -
Beverley M. Shields,
Timothy J. McDonald,
Richard A. Oram,
Anita Hill,
Michelle Hudson,
Pia Leete,
Ewan R. Pearson,
Sarah J. Richardson,
Noel G. Morgan,
Andrew T. Hattersley,
Bart O. Roep,
Timothy Tree,
S. Hammersley,
R. F. Bolt
Publication year - 2018
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc18-0465
Subject(s) - medicine , diabetes mellitus , c peptide , type 1 diabetes , longitudinal study , creatinine , demography , peptide , endocrinology , biology , pathology , biochemistry , sociology
The decline in C-peptide in the 5 years after diagnosis of type 1 diabetes has been well studied, but little is known about the longer-term trajectory. We aimed to examine the association between log-transformed C-peptide levels and the duration of diabetes up to 40 years after diagnosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom